Megatrials in type 2 diabetes. From excitement to frustration?-Reference-Cited by-同舟云学术

Megatrials in type 2 diabetes. From excitement to frustration?

Published:2009-04-17 Issue:7 Volume:52 Page:1219-1226
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Del Prato S.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-009-1352-5.pdf

Reference41 articles.

1. University Group Diabetes Program (UGDP) (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19(Suppl 2):747–830

2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

3. Genuth S, Eastman R, Kahn R, American Diabetes Association et al (2003) Implications of the United Kingdom prospective diabetes study. Diabetes Care 26:S28–S32

4. Ohkubo Y, Kishikawa H, Araki E et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117

5. Dormandy JA, Charbonnel B, Eckland DJ (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279–1289

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk;Atherosclerosis;2024-07

2. Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability;Diabetes, Obesity and Metabolism;2024-05-27

3. Metabolic memory: mechanisms and diseases;Signal Transduction and Targeted Therapy;2024-02-28

4. Early treatment with dipeptidyl‐peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score‐matched cohort study;Diabetes/Metabolism Research and Reviews;2023-08-26

5. Multimodale kardiovaskuläre Prävention;Springer Reference Medizin;2023